Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin’s disease

This publication has 28 references indexed in Scilit:

• Salvage radiotherapy for hodgkin's disease following chemotherapy failure
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
  Journal of Clinical Oncology, 1997
• High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
  Blood, 1995
• Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.
  Journal of Clinical Oncology, 1993
• High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.
  Journal of Clinical Oncology, 1993
• Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
  Journal of Clinical Oncology, 1992
• Autologous bone marrow transplantation for patients with relapsed hodgkin's disease
  The American Journal of Medicine, 1991
• High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease [published erratum appears in Blood 1991 Dec 15;78(12):3330]
  Blood, 1991
• High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
  Journal of Clinical Oncology, 1990
• Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation
  Blood, 1989